Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): An Extension Study (ROMANA 3)

NCT01395914 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

513

Enrollment

INDUSTRY

Sponsor class

Conditions

Cachexia
Non-Small Cell Lung Cancer

Interventions

DRUG: Anamorelin HCl
DRUG: Placebo

Sponsor

Helsinn Therapeutics (U.S.), Inc